diagnostic imaging, and access-related procedures including those pertaining to access maturation. These events were designated as occurring within either the first or second year of functional access patency. Current procedural terminology codes were used to calculate the unadjusted Medicare, or "national average," reimbursement in 2012 US dollars for these events as outpatient hospital encounters. Bivariate analysis using linear modeling and one-way analysis of variance was used to assess differences in mean cost.
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Results: RCFs and BCFs had higher 1-year functional patency costs in females than in males ($19,257 vs $15,089 and $17,275 vs $13,819) regardless of age. This remained statistically significant with respect to 2-year functional patency ($48,362 vs $42,372 and $43,361 vs $37,651) . RCF and BCF were costlier in patients over the age of 70 than BBF ($23,492 vs $22,984 vs $14,089) regardless of gender over the first year of access functional patency. This difference remained at 2 years as well ($53,251 vs $56,261 vs $39,372) . Among females over age 70, the cost of maintaining BBF was less expensive than in males or younger females ($13,247 vs $16,668 or $15,827) during the first year as well as the second year ($33,374 vs $44,726 or $44,324) . All mentioned differences demonstrated statistical significance with a P value of <.05.
Conclusions: Sex, age, and anatomic location may correlate with cost differences in maintaining 1-and 2-year functional patency of AVFs. These financial differences may further be stratified by patient demographics. Methods: Carotid plaques were sectioned and incubated in culture medium at 37 C. Samples were treated with the NLBs of different polymer chemistries and 5 mg/mL oxLDL to evaluate NLB binding to plaque and to assess inhibition of plaque recruitment of OxLDL and effect on inflammation. Samples were digested, homogenized, filtered, and fluorescence quantified by flow cytometry and confocal microscopy to identify plaque composition, NLB, and oxLDL uptake.
Results: Plaque cells were identified in the specimen showing high levels of NLB binding, merely within 5 minutes, with an increase in uptake in a chemistry-dependent manner after 24 hours (Fig 1) . NLBs lowered inflammatory markers in the presence of oxLDL. Furthermore, NLBs caused a marked decrease in the uptake of OxLDL in plaque (Fig 2) .
Conclusions: AthSc plaques could be targeted through NLB intervention via a reduction in inflammatory substrates and multicellular OxLDL uptake inhibition. This ex vivo model and the NLBs provide a promising therapeutic strategy for the management of active AthSc. Objectives: Impending changes to hospital reimbursement has focused attention on the significant impact of unplanned hospital readmissions on both patients and providers alike. Vascular surgery patients have high readmission rates and identification of high-risk groups that may be amenable to targeted interventions is an important strategy for readmission prevention. This study aimed to determine predictors of unplanned readmission and develop a risk score for predicting readmissions after vascular surgery.
Risk Score for Unplanned 30-Day Readmissions after Major Vascular Surgery Procedures
Methods: The National Surgical Quality Improvement Program database for 2011 was queried for major vascular surgical procedures. The primary end point was unplanned 30-day readmissions. The data was randomly split into two-thirds for development and one-third for validation. Multivariate logistic regression was used to create and validate a point score system to predict unplanned readmissions.
Results: Overall 24,310 patients were included, with 2464 readmissions (10.1%). A point based scoring system was developed based on multivariate logistic regression for factors predictive for readmission (Table) . The scoring system developed included procedure type (open abdominal aortic aneurysm ¼ 3 points, peripheral intervention 5 points, amputation ¼ 1 point), graft failure prior to discharge (5 points), venothromboembolism prior to discharge (4 points), discharge destination (facility that was home ¼ 3-points, new facility or rehab ¼ 2 points), Black race (1 point), nonelective presentation (1 point), pulmonary (2 points), cardiac (2 points), renal (1 point) comorbidities, chronic steroid use (2 points), hypoalbuminemia (2 points), anemia (2 points), diabetes (1 point), bleeding disorder (1 point), operative time $150 minutes (1 point), and bleeding disorder (1 point). The point score was used to stratify patients into three groups: low risk (0-3 points) with a readmission rate of 5.4%, moderate risk (4-7 points) with a readmission rate of 8.6%, and high risk ($8 points) with a readmission rate of 16.4%. The model had good predictive ability (c-statistic ¼ 0.67).
Conclusions: Using patient, operative, and predischarge events, this novel vascular surgery specific readmission score accurately identified patients at high risk for 30-day unplanned readmission. This model could help direct discharge and home health care resources to patients at high risk, ultimately reducing readmissions and improving efficiency. Abstracts 1149
